Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Plasma 5-miRNA as Biomarkers for Identifying Prostate Cancer Patients.

Saffari M, Modarressi MH, Shirkoohi R, Hassani B, Afsharpad M, Rafiei G, Abroodi G, Yekaninejad MS, Arfaee J, Akrami SM.

Iran J Public Health. 2019 Sep;48(9):1743-1745. No abstract available.

2.

Differential Expression Pattern of Epithelial Mesenchymal Transition Gens: AXL, GAS6, Claudin-1, and Cofilin-1, in Different Stages of Epithelial Ovarian Cancer.

Hassani E, Shekari Khaniani M, Saffari M, Emami Razavi A, Shirkoohi R, Mansoori Derakhshan S.

Iran J Public Health. 2019 Sep;48(9):1723-1731.

3.

Fibroblast growth factor-10 and epithelial-mesenchymal transition in colorectal cancer.

Farajihaye Qazvini F, Samadi N, Saffari M, Emami-Razavi AN, Shirkoohi R.

EXCLI J. 2019 Jul 17;18:530-539. doi: 10.17179/excli2018-1784. eCollection 2019.

4.

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.

Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, Abdelalim A, Abdoli A, Abdollahpour I, Abdulle ASM, Abebe ND, Abraha HN, Abu-Raddad LJ, Abualhasan A, Adedeji IA, Advani SM, Afarideh M, Afshari M, Aghaali M, Agius D, Agrawal S, Ahmadi A, Ahmadian E, Ahmadpour E, Ahmed MB, Akbari ME, Akinyemiju T, Al-Aly Z, AlAbdulKader AM, Alahdab F, Alam T, Alamene GM, Alemnew BTT, Alene KA, Alinia C, Alipour V, Aljunid SM, Bakeshei FA, Almadi MAH, Almasi-Hashiani A, Alsharif U, Alsowaidi S, Alvis-Guzman N, Amini E, Amini S, Amoako YA, Anbari Z, Anber NH, Andrei CL, Anjomshoa M, Ansari F, Ansariadi A, Appiah SCY, Arab-Zozani M, Arabloo J, Arefi Z, Aremu O, Areri HA, Artaman A, Asayesh H, Asfaw ET, Ashagre AF, Assadi R, Ataeinia B, Atalay HT, Ataro Z, Atique S, Ausloos M, Avila-Burgos L, Avokpaho EFGA, Awasthi A, Awoke N, Ayala Quintanilla BP, Ayanore MA, Ayele HT, Babaee E, Bacha U, Badawi A, Bagherzadeh M, Bagli E, Balakrishnan S, Balouchi A, Bärnighausen TW, Battista RJ, Behzadifar M, Behzadifar M, Bekele BB, Belay YB, Belayneh YM, Berfield KKS, Berhane A, Bernabe E, Beuran M, Bhakta N, Bhattacharyya K, Biadgo B, Bijani A, Bin Sayeed MS, Birungi C, Bisignano C, Bitew H, Bjørge T, Bleyer A, Bogale KA, Bojia HA, Borzì AM, Bosetti C, Bou-Orm IR, Brenner H, Brewer JD, Briko AN, Briko NI, Bustamante-Teixeira MT, Butt ZA, Carreras G, Carrero JJ, Carvalho F, Castro C, Castro F, Catalá-López F, Cerin E, Chaiah Y, Chanie WF, Chattu VK, Chaturvedi P, Chauhan NS, Chehrazi M, Chiang PP, Chichiabellu TY, Chido-Amajuoyi OG, Chimed-Ochir O, Choi JJ, Christopher DJ, Chu DT, Constantin MM, Costa VM, Crocetti E, Crowe CS, Curado MP, Dahlawi SMA, Damiani G, Darwish AH, Daryani A, das Neves J, Demeke FM, Demis AB, Demissie BW, Demoz GT, Denova-Gutiérrez E, Derakhshani A, Deribe KS, Desai R, Desalegn BB, Desta M, Dey S, Dharmaratne SD, Dhimal M, Diaz D, Dinberu MTT, Djalalinia S, Doku DT, Drake TM, Dubey M, Dubljanin E, Duken EE, Ebrahimi H, Effiong A, Eftekhari A, El Sayed I, Zaki MES, El-Jaafary SI, El-Khatib Z, Elemineh DA, Elkout H, Ellenbogen RG, Elsharkawy A, Emamian MH, Endalew DA, Endries AY, Eshrati B, Fadhil I, Fallah V, Faramarzi M, Farhangi MA, Farioli A, Farzadfar F, Fentahun N, Fernandes E, Feyissa GT, Filip I, Fischer F, Fisher JL, Force LM, Foroutan M, Freitas M, Fukumoto T, Futran ND, Gallus S, Gankpe FG, Gayesa RT, Gebrehiwot TT, Gebremeskel GG, Gedefaw GA, Gelaw BK, Geta B, Getachew S, Gezae KE, Ghafourifard M, Ghajar A, Ghashghaee A, Gholamian A, Gill PS, Ginindza TTG, Girmay A, Gizaw M, Gomez RS, Gopalani SV, Gorini G, Goulart BNG, Grada A, Ribeiro Guerra M, Guimaraes ALS, Gupta PC, Gupta R, Hadkhale K, Haj-Mirzaian A, Haj-Mirzaian A, Hamadeh RR, Hamidi S, Hanfore LK, Haro JM, Hasankhani M, Hasanzadeh A, Hassen HY, Hay RJ, Hay SI, Henok A, Henry NJ, Herteliu C, Hidru HD, Hoang CL, Hole MK, Hoogar P, Horita N, Hosgood HD, Hosseini M, Hosseinzadeh M, Hostiuc M, Hostiuc S, Househ M, Hussen MM, Ileanu B, Ilic MD, Innos K, Irvani SSN, Iseh KR, Islam SMS, Islami F, Jafari Balalami N, Jafarinia M, Jahangiry L, Jahani MA, Jahanmehr N, Jakovljevic M, James SL, Javanbakht M, Jayaraman S, Jee SH, Jenabi E, Jha RP, Jonas JB, Jonnagaddala J, Joo T, Jungari SB, Jürisson M, Kabir A, Kamangar F, Karch A, Karimi N, Karimian A, Kasaeian A, Kasahun GG, Kassa B, Kassa TD, Kassaw MW, Kaul A, Keiyoro PN, Kelbore AG, Kerbo AA, Khader YS, Khalilarjmandi M, Khan EA, Khan G, Khang YH, Khatab K, Khater A, Khayamzadeh M, Khazaee-Pool M, Khazaei S, Khoja AT, Khosravi MH, Khubchandani J, Kianipour N, Kim D, Kim YJ, Kisa A, Kisa S, Kissimova-Skarbek K, Komaki H, Koyanagi A, Krohn KJ, Bicer BK, Kugbey N, Kumar V, Kuupiel D, La Vecchia C, Lad DP, Lake EA, Lakew AM, Lal DK, Lami FH, Lan Q, Lasrado S, Lauriola P, Lazarus JV, Leigh J, Leshargie CT, Liao Y, Limenih MA, Listl S, Lopez AD, Lopukhov PD, Lunevicius R, Madadin M, Magdeldin S, El Razek HMA, Majeed A, Maleki A, Malekzadeh R, Manafi A, Manafi N, Manamo WA, Mansourian M, Mansournia MA, Mantovani LG, Maroufizadeh S, Martini SMS, Mashamba-Thompson TP, Massenburg BB, Maswabi MT, Mathur MR, McAlinden C, McKee M, Meheretu HAA, Mehrotra R, Mehta V, Meier T, Melaku YA, Meles GG, Meles HG, Melese A, Melku M, Memiah PTN, Mendoza W, Menezes RG, Merat S, Meretoja TJ, Mestrovic T, Miazgowski B, Miazgowski T, Mihretie KMM, Miller TR, Mills EJ, Mir SM, Mirzaei H, Mirzaei HR, Mishra R, Moazen B, Mohammad DK, Mohammad KA, Mohammad Y, Darwesh AM, Mohammadbeigi A, Mohammadi H, Mohammadi M, Mohammadian M, Mohammadian-Hafshejani A, Mohammadoo-Khorasani M, Mohammadpourhodki R, Mohammed AS, Mohammed JA, Mohammed S, Mohebi F, Mokdad AH, Monasta L, Moodley Y, Moosazadeh M, Moossavi M, Moradi G, Moradi-Joo M, Moradi-Lakeh M, Moradpour F, Morawska L, Morgado-da-Costa J, Morisaki N, Morrison SD, Mosapour A, Mousavi SM, Muche AA, Muhammed OSS, Musa J, Nabhan AR, Naderi M, Nagarajan AJ, Nagel G, Nahvijou A, Naik G, Najafi F, Naldi L, Nam HS, Nasiri N, Nazari J, Negoi I, Neupane S, Newcomb PA, Nggada HA, Ngunjiri JW, Nguyen CT, Nikniaz L, Ningrum DNA, Nirayo YL, Nixon MR, Nnaji CA, Nojomi M, Nosratnejad S, Shiadeh MN, Obsa MS, Ofori-Asenso R, Ogbo FA, Oh IH, Olagunju AT, Olagunju TO, Oluwasanu MM, Omonisi AE, Onwujekwe OE, Oommen AM, Oren E, Ortega-Altamirano DDV, Ota E, Otstavnov SS, Owolabi MO, P A M, Padubidri JR, Pakhale S, Pakpour AH, Pana A, Park EK, Parsian H, Pashaei T, Patel S, Patil ST, Pennini A, Pereira DM, Piccinelli C, Pillay JD, Pirestani M, Pishgar F, Postma MJ, Pourjafar H, Pourmalek F, Pourshams A, Prakash S, Prasad N, Qorbani M, Rabiee M, Rabiee N, Radfar A, Rafiei A, Rahim F, Rahimi M, Rahman MA, Rajati F, Rana SM, Raoofi S, Rath GK, Rawaf DL, Rawaf S, Reiner RC, Renzaho AMN, Rezaei N, Rezapour A, Ribeiro AI, Ribeiro D, Ronfani L, Roro EM, Roshandel G, Rostami A, Saad RS, Sabbagh P, Sabour S, Saddik B, Safiri S, Sahebkar A, Salahshoor MR, Salehi F, Salem H, Salem MR, Salimzadeh H, Salomon JA, Samy AM, Sanabria J, Santric Milicevic MM, Sartorius B, Sarveazad A, Sathian B, Satpathy M, Savic M, Sawhney M, Sayyah M, Schneider IJC, Schöttker B, Sekerija M, Sepanlou SG, Sepehrimanesh M, Seyedmousavi S, Shaahmadi F, Shabaninejad H, Shahbaz M, Shaikh MA, Shamshirian A, Shamsizadeh M, Sharafi H, Sharafi Z, Sharif M, Sharifi A, Sharifi H, Sharma R, Sheikh A, Shirkoohi R, Shukla SR, Si S, Siabani S, Silva DAS, Silveira DGA, Singh A, Singh JA, Sisay S, Sitas F, Sobngwi E, Soofi M, Soriano JB, Stathopoulou V, Sufiyan MB, Tabarés-Seisdedos R, Tabuchi T, Takahashi K, Tamtaji OR, Tarawneh MR, Tassew SG, Taymoori P, Tehrani-Banihashemi A, Temsah MH, Temsah O, Tesfay BE, Tesfay FH, Teshale MY, Tessema GA, Thapa S, Tlaye KG, Topor-Madry R, Tovani-Palone MR, Traini E, Tran BX, Tran KB, Tsadik AG, Ullah I, Uthman OA, Vacante M, Vaezi M, Varona Pérez P, Veisani Y, Vidale S, Violante FS, Vlassov V, Vollset SE, Vos T, Vosoughi K, Vu GT, Vujcic IS, Wabinga H, Wachamo TM, Wagnew FS, Waheed Y, Weldegebreal F, Weldesamuel GT, Wijeratne T, Wondafrash DZ, Wonde TE, Wondmieneh AB, Workie HM, Yadav R, Yadegar A, Yadollahpour A, Yaseri M, Yazdi-Feyzabadi V, Yeshaneh A, Yimam MA, Yimer EM, Yisma E, Yonemoto N, Younis MZ, Yousefi B, Yousefifard M, Yu C, Zabeh E, Zadnik V, Moghadam TZ, Zaidi Z, Zamani M, Zandian H, Zangeneh A, Zaki L, Zendehdel K, Zenebe ZM, Zewale TA, Ziapour A, Zodpey S, Murray CJL.

JAMA Oncol. 2019 Sep 27. doi: 10.1001/jamaoncol.2019.2996. [Epub ahead of print]

5.

The NCCN Criterion "Young Age at Onset" Alone is Not an Indicator of Hereditary Breast Cancer in Iranian Population.

Ebrahimi E, Sellars E, Shirkoohi R, Harirchi I, Ghiasvand R, Mohebbi E, Zendehdel K, Akbari MR.

Cancer Prev Res (Phila). 2019 Nov;12(11):763-770. doi: 10.1158/1940-6207.CAPR-19-0056. Epub 2019 Aug 26.

PMID:
31451522
6.

DNA hypermethylation of GDF5 in developmental dysplasia of the hip (DDH).

Baghdadi T, Nejadhosseinian M, Shirkoohi R, Mostafavi Tabatabaee R, Tamehri SS, Saffari M, Mortazavi SMJ.

Mol Genet Genomic Med. 2019 Sep;7(9):e887. doi: 10.1002/mgg3.887. Epub 2019 Jul 23.

7.

Precision in Oncology; a Future Prospect

Shirkoohi R.

Asian Pac J Cancer Prev. 2018 Jul 27;19(7):1739-1740. No abstract available.

8.

Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors.

Ebrahimi E, Almasi-Hashiani A, Ghaffari K, Shirkoohi R.

EXCLI J. 2018 Jan 22;17:149-158. doi: 10.17179/excli2017-819. eCollection 2018.

9.

Author Correction: Opium Consumption and the Incidence of Cancer: Does Opium Account as an Emerging Risk Factor for Gastrointestinal Cancer?

Alzaidi MA, Arab HA, Amanpour S, Shirkoohi R, Muhammadnejad S, Sasani F.

J Gastrointest Cancer. 2018 Jun;49(2):181. doi: 10.1007/s12029-018-0086-3.

PMID:
29569059
10.

Opium Consumption and the Incidence of Cancer: Does Opium Account as an Emerging Risk Factor for Gastrointestinal Cancer?

Alzaidi MA, Arab HA, Amanpour S, Shirkoohi R, Muhammadnejad S, Sasani F.

J Gastrointest Cancer. 2018 Jun;49(2):172-180. doi: 10.1007/s12029-017-0050-7. Erratum in: J Gastrointest Cancer. 2018 Mar 22;:.

PMID:
29362985
11.

Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran.

Farrokhi M, Moallemi S, Shirkoohi R, Golmohammadi R, Ahsani-Nasab S, Sardashti S, Abbasian L, Baesi K, Mohraz M.

Iran J Public Health. 2017 Sep;46(9):1256-1264.

12.

The association of vimentin and fibronectin gene expression with epithelial-mesenchymal transition and tumor malignancy in colorectal carcinoma.

Niknami Z, Eslamifar A, Emamirazavi A, Ebrahimi A, Shirkoohi R.

EXCLI J. 2017 Jul 10;16:1009-1017. doi: 10.17179/excli2017-481. eCollection 2017.

13.

CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran.

Ebrahimi E, Sabokbar T, Eskandarieh S, Peyghambari V, Shirkoohi R.

Iran J Public Health. 2017 Apr;46(4):537-544.

14.

A Patient With Desmoid Tumors and Familial FAP Having Frame Shift Mutation of the APC Gene.

Sadighi S, Ghaffari-Moghaddam M, Saffari M, Mohagheghi MA, Shirkoohi R.

Acta Med Iran. 2017 Feb;55(2):134-138.

15.

Synaptonemal Complex Protein 3 Transcript Analysis in Breast Cancer.

Mobasheri MB, Shirkoohi R, Modarressi MH.

Iran J Public Health. 2016 Dec;45(12):1618-1624.

16.

Synthesis of a novel PEGDGA-coated hPAMAM complex as an efficient and biocompatible gene delivery vector: an in vitro and in vivo study.

Hemmati M, Najafi F, Shirkoohi R, Moghimi HR, Zarebkohan A, Kazemi B.

Drug Deliv. 2016 Oct;23(8):2956-2969. Epub 2016 Aug 5.

PMID:
27494752
17.

BIRC5 Genomic Copy Number Variation in Early-Onset Breast Cancer.

Ghaffari K, Hashemi M, Ebrahimi E, Shirkoohi R.

Iran Biomed J. 2016 Sep;20(4):241-5.

18.

Melanoma in Iran: a Retrospective 10-Year Study.

Ferdosi S, Saffari M, Eskandarieh S, Raziyeh R, Moghaddam MG, Ghanadan A, Shirkoohi R.

Asian Pac J Cancer Prev. 2016;17(6):2751-5.

19.

JAK2V617F Allele Burden Measurement in Peripheral Blood of Iranian Patients with Myeloproliferative Neoplasms and Effect of Hydroxyurea on JAK2V617F Allele Burden.

Ferdowsi S, Ghaffari SH, Amirizadeh N, Azarkeivan A, Atarodi K, Faranoush M, Toogeh G, Shirkoohi R, Vaezi M, Maghsoodlu M, Alimoghaddam K, Ghavamzadeh A, Teimori Naghadeh H.

Int J Hematol Oncol Stem Cell Res. 2016 Apr 1;10(2):70-8.

20.

Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway.

Rashidian A, Muhammadnejad A, Dehpour AR, Mehr SE, Akhavan MM, Shirkoohi R, Chamanara M, Mousavi SE, Rezayat SM.

Inflammopharmacology. 2016 Jun;24(2-3):109-18. doi: 10.1007/s10787-016-0263-6. Epub 2016 Apr 2.

PMID:
27038922
21.

Synthesis and evaluation of a glutamic acid-modified hPAMAM complex as a promising versatile gene carrier.

Hemmati M, Kazemi B, Najafi F, Zarebkohan A, Shirkoohi R.

J Drug Target. 2016;24(5):408-21. doi: 10.3109/1061186X.2015.1078338. Epub 2015 Sep 4.

PMID:
26339844
22.

Cancer/Testis OIP5 and TAF7L Genes are Up-Regulated in Breast Cancer.

Mobasheri MB, Shirkoohi R, Modarressi MH.

Asian Pac J Cancer Prev. 2015;16(11):4623-8.

23.

Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines.

Mobasheri MB, Shirkoohi R, Zendehdel K, Jahanzad I, Talebi S, Afsharpad M, Modarressi MH.

Tumour Biol. 2015 Sep;36(10):8201-6. doi: 10.1007/s13277-015-3546-4. Epub 2015 May 21.

PMID:
25994570
24.

Feasibility assessment of in vitro chemoresponse assay on stereotactic biopsies of glioblastoma multiforms: a step towards personalized medicine.

Sadeghi Fazel F, Haddadi M, Khoshnevisan A, Muhammadnejad S, Muhammadnejad A, Mazaheri Z, Arjomandnejad M, Shirkoohi R, Oghabian MA, Sherkat-Khameneh N, Amanpour S, Kazemimanesh M.

Iran J Basic Med Sci. 2014 Nov;17(11):922-5.

25.

Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.

Mirzaei A, Tavoosidana G, Modarressi MH, Rad AA, Fazeli MS, Shirkoohi R, Tavakoli-Yaraki M, Madjd Z.

Tumour Biol. 2015 Jun;36(6):4801-10. doi: 10.1007/s13277-015-3132-9. Epub 2015 Jan 29.

PMID:
25631749
26.

Overexpression of enhancer of zeste human homolog 2 (EZH2) gene in human cytomegalovirus positive glioblastoma multiforme tissues.

Ahani N, Shirkoohi R, Rokouei M, Alipour Eskandani M, Nikravesh A.

Med Oncol. 2014 Nov;31(11):252. doi: 10.1007/s12032-014-0252-9. Epub 2014 Oct 8.

PMID:
25294424
27.

FGF10: Type III Epithelial Mesenchymal Transition and Invasion in Breast Cancer Cell Lines.

Abolhassani A, Riazi GH, Azizi E, Amanpour S, Muhammadnejad S, Haddadi M, Zekri A, Shirkoohi R.

J Cancer. 2014 Jun 21;5(7):537-47. doi: 10.7150/jca.7797. eCollection 2014.

28.

A registry program for familial gastric cancer patients referred to Cancer Institute of Iran.

Etemadi M, Pourian M, Shakib A, Sabokbar T, Peyghanbari V, Shirkoohi R.

Asian Pac J Cancer Prev. 2014;15(5):2141-4.

29.

Expression of insulin-like growth factor binding protein-2 (IGFBP-2) gene in negative and positive human cytomegalovirus glioblastoma multiforme tissues.

Ahani N, Karimi Arzenani M, Shirkoohi R, Rokouei M, Alipour Eskandani M, Nikravesh A.

Med Oncol. 2014 Feb;31(2):812. doi: 10.1007/s12032-013-0812-4. Epub 2013 Dec 19.

PMID:
24352760
30.

Neoplasia from genetic point of view.

Shirkoohi R, Azimi C.

Acta Med Iran. 2013;51(10):663-74. Review.

31.

Induction of Apoptosis and Growth Suppression by Homeobox Gene TGIFLX in Prostate Cancer Cell Line Lncap.

Rashvand Z, Heidari M, Raoofian R, Modarresi MH, Shirkoohi R.

Iran J Public Health. 2013 Nov;42(11):1242-52.

32.
33.

Expression analysis of four testis-specific genes AURKC, OIP5, PIWIL2 and TAF7L in acute myeloid leukemia: a gender-dependent expression pattern.

Yazarloo F, Shirkoohi R, Mobasheri MB, Emami A, Modarressi MH.

Med Oncol. 2013 Mar;30(1):368. doi: 10.1007/s12032-012-0368-8. Epub 2013 Jan 6.

PMID:
23292864
34.

Epithelial mesenchymal transition from a natural gestational orchestration to a bizarre cancer disturbance.

Shirkoohi R.

Cancer Sci. 2013 Jan;104(1):28-35. doi: 10.1111/cas.12074. Epub 2012 Dec 31. Review.

35.

Gelsolin induces promonocytic leukemia differentiation accompanied by upregulation of p21CIP1.

Shirkoohi R, Fujita H, Darmanin S, Takimoto M.

Asian Pac J Cancer Prev. 2012;13(9):4827-34.

36.

Familial breast cancer registry program in patients referred to the cancer institute of Iran.

Sabokbar T, Khajeh E, Taghdiri F, Peyghambari V, Shirkoohi R.

Asian Pac J Cancer Prev. 2012;13(6):2675-9.

37.

Expression analysis of MiR-21, MiR-205, and MiR-342 in breast cancer in Iran.

Savad S, Mehdipour P, Miryounesi M, Shirkoohi R, Fereidooni F, Mansouri F, Modarressi MH.

Asian Pac J Cancer Prev. 2012;13(3):873-7.

38.

Concomitant presence of JAK2 V617F mutation and BCR-ABL translocation in a pregnant woman with polycythemia vera.

Toogeh G, Ferdowsi S, Naadali F, Alimoghaddam K, Ghavamzadeh A, Shirkoohi R, Ghaffari SH.

Med Oncol. 2011 Dec;28(4):1555-8. doi: 10.1007/s12032-010-9570-8. Epub 2010 May 25.

PMID:
20499211
39.

Antibodies against structural and nonstructural proteins of human bocavirus in human sera.

Shirkoohi R, Endo R, Ishiguro N, Teramoto S, Kikuta H, Ariga T.

Clin Vaccine Immunol. 2010 Jan;17(1):190-3. doi: 10.1128/CVI.00355-09. Epub 2009 Dec 2.

40.

All-trans retinoic acid enhances murine dendritic cell migration to draining lymph nodes via the balance of matrix metalloproteinases and their inhibitors.

Darmanin S, Chen J, Zhao S, Cui H, Shirkoohi R, Kubo N, Kuge Y, Tamaki N, Nakagawa K, Hamada J, Moriuchi T, Kobayashi M.

J Immunol. 2007 Oct 1;179(7):4616-25.

41.

Seroepidemiology of human bocavirus in Hokkaido prefecture, Japan.

Endo R, Ishiguro N, Kikuta H, Teramoto S, Shirkoohi R, Ma X, Ebihara T, Ishiko H, Ariga T.

J Clin Microbiol. 2007 Oct;45(10):3218-23. Epub 2007 Aug 15.

42.

[Ability of actin-regulatory protein, gelsolin in induction of monocytic leukemia cell differentiation].

Shirkoohi R.

Hokkaido Igaku Zasshi. 2006 Mar;81(2):159-67. Japanese. No abstract available.

PMID:
16669119
43.

siRNA gelsolin knockdown induces epithelial-mesenchymal transition with a cadherin switch in human mammary epithelial cells.

Tanaka H, Shirkoohi R, Nakagawa K, Qiao H, Fujita H, Okada F, Hamada J, Kuzumaki S, Takimoto M, Kuzumaki N.

Int J Cancer. 2006 Apr 1;118(7):1680-91.

Supplemental Content

Loading ...
Support Center